The COVID-19 pandemic, caused by the highly pathogenic coronavirus (SARS-CoV-2 virus), is spreading quickly, causing fever, cough, and shortness of breath. Scientists all over the world are intensively working to find solutions to fight this and other viruses—from pathogen detection through antiviral treatments, to the development of novel vaccines.
ibidi, as a global supplier of solutions for cell-based assays, supports many virology-related preclinical studies. In the current urgency to develop vaccines against virus-related diseases, academic institutes and biopharmaceutical companies worldwide rely on ibidi labware, instruments, and reagents. Various publications in reputable scientific journals reflect the importance of ibidi’s ongoing contribution to this research area.

During the pandemic, the safety and well-being of the ibidi employees is our top priority. Every employee is strictly following the guidelines from all respective governments and health organizations. We have implemented procedures to allow our business operations to continue, and thus guarantee that our customers receive the support they need.

  • Our R&D team is currently focusing on developing solutions that can aid COVID-19 research. Please contact us at [email protected], if you would like to cooperate with ibidi on a specific assay.
  • Our production team is on-site to ensure that every ibidi product is continuously available.
  • The ibidi sales and service team is fully operational. If you have any questions or if you need technical support, please contact us.

Read on and learn more about ibidi Solutions for Virology Research available on the market, or explore the ibidi Prototypes for Virology Research that are currently in development.